Published in Evid Based Complement Alternat Med on September 01, 2005
Ki-energy (life-energy) protects isolated rat liver mitochondria from oxidative injury. Evid Based Complement Alternat Med (2006) 1.41
The Nishino Breathing Method and Ki-energy (Life-energy): A Challenge to Traditional Scientific Thinking. Evid Based Complement Alternat Med (2006) 1.28
What is qi? Evid Based Complement Alternat Med (2006) 1.22
Ki: a key to transform the century of death to the century of life. Evid Based Complement Alternat Med (2007) 0.87
eCAM: On To Year 4. Evid Based Complement Alternat Med (2006) 0.87
Ki-energy (life-energy) stimulates osteoblastic cells and inhibits the formation of osteoclast-like cells in bone cell culture models. Evid Based Complement Alternat Med (2007) 0.84
Qigong ameliorates symptoms of chronic fatigue: a pilot uncontrolled study. Evid Based Complement Alternat Med (2007) 0.82
How Far Can Ki-energy Reach?--A Hypothetical Mechanism for the Generation and Transmission of Ki-energy. Evid Based Complement Alternat Med (2007) 0.75
Philosophy, psychology, physics and practice of ki. Evid Based Complement Alternat Med (2008) 0.75
Radiation response of cultured human cells is unaffected by Johrei. Evid Based Complement Alternat Med (2006) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48
Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1992) 17.40
Nucleotide sequence of cloned cDNA of human c-myc oncogene. Nature (1983) 4.83
Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. J Biol Chem (1993) 1.51
Beneficial effects of the Nishino breathing method on immune activity and stress level. J Altern Complement Med (2005) 1.42
In vitro test of external Qigong. BMC Complement Altern Med (2004) 1.09
An analytic review of studies on measuring effects of external QI in China. Altern Ther Health Med (2004) 1.02
Protective effect of XY99-5038 on hydrogen peroxide induced cell death in cultured retinal neurons. Life Sci (2001) 0.96
Suppression of cell proliferation and deoxyribonucleic acid synthesis in the cloned rat hepatoma H4-II-E cells overexpressing regucalcin. J Cell Biochem (2001) 0.93
p53-dependent hyperthermic enhancement of tumour growth inhibition by X-ray or carbon-ion beam irradiation. Int J Hyperthermia (2003) 0.92
Effect of emitted bioenergy on biochemical functions of cells. Am J Chin Med (1991) 0.92
Therapeutic benefits of qigong exercises in combination with drugs. J Altern Complement Med (1999) 0.92
Effects of in vitro and in vivo Qi-therapy on neutrophil superoxide generation in healthy male subjects. Am J Chin Med (2003) 0.91
Radiation-induced growth inhibition in transplanted human tongue carcinomas with different p53 gene status. Anticancer Res (2002) 0.91
Evidence of Qi-gong energy and its biological effect on the enhancement of the phagocytic activity of human polymorphonuclear leukocytes. Am J Chin Med (2001) 0.90
Effects of emitted Qi on in vitro natural killer cell cytotoxic activity. Am J Chin Med (2001) 0.90
Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells. J Cell Biochem (2003) 0.89
Biofield perception: a series of pilot studies with cultured human cells. J Altern Complement Med (2004) 0.88
A preliminary study of the effect of external qigong on lymphoma growth in mice. J Altern Complement Med (2002) 0.88
The role of regucalcin in nuclear regulation of regenerating liver. Biochem Biophys Res Commun (2000) 0.87
Transcript heterogeneity of the human gene for Ca2+-binding protein regucalcin. Int J Mol Med (2000) 0.86
The antitumor effects of qigong-emitted external Qi and its influence on the immunologic functions of tumor-bearing mice. J Tongji Med Univ (1991) 0.86
Tissue concentration of calcium-binding protein regucalcin in rats by enzyme-linked immunoadsorbent assay. Mol Cell Biochem (1993) 0.86
Expression of calcium-binding protein regucalcin mRNA in the cloned human hepatoma cells (HepG2): stimulation by insulin. Mol Cell Biochem (1997) 0.86
XY99-5038 promotes long-term survival of cultured retinal neurons. Int J Neurosci (2002) 0.85
Translocation of regucalcin to rat liver nucleus: involvement of nuclear protein kinase and protein phosphatase regulation. Int J Mol Med (2000) 0.85
De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet (2013) 4.71
Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Hum Mutat (2010) 1.83
A proteomics approach to the cell-surface interactome using the enzyme-mediated activation of radical sources reaction. Proteomics (2011) 1.54
Dre2, a conserved eukaryotic Fe/S cluster protein, functions in cytosolic Fe/S protein biogenesis. Mol Cell Biol (2008) 1.47
Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy. Am J Hum Genet (2013) 1.46
Ki-energy (life-energy) protects isolated rat liver mitochondria from oxidative injury. Evid Based Complement Alternat Med (2006) 1.41
Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia (2014) 1.38
Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A (2010) 1.38
KDM6A point mutations cause Kabuki syndrome. Hum Mutat (2012) 1.35
Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia (2013) 1.35
Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome. Ann Neurol (2012) 1.34
Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. Neurogenetics (2013) 1.32
A possible site of superoxide generation in the complex I segment of rat heart mitochondria. J Bioenerg Biomembr (2005) 1.28
The Nishino Breathing Method and Ki-energy (Life-energy): A Challenge to Traditional Scientific Thinking. Evid Based Complement Alternat Med (2006) 1.28
De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet (2013) 1.27
Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species. Biochim Biophys Acta (2008) 1.26
Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am J Hum Genet (2011) 1.24
The membrane subunit NuoL(ND5) is involved in the indirect proton pumping mechanism of Escherichia coli complex I. J Biol Chem (2010) 1.23
Characterization of the delta muH+-sensitive ubisemiquinone species (SQ(Nf)) and the interaction with cluster N2: new insight into the energy-coupled electron transfer in complex I. Biochemistry (2005) 1.22
Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome. Neurology (2013) 1.19
MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet A (2013) 1.19
EPR characterization of ubisemiquinones and iron-sulfur cluster N2, central components of the energy coupling in the NADH-ubiquinone oxidoreductase (complex I) in situ. J Bioenerg Biomembr (2002) 1.17
Binding dynamics at the quinone reduction (Qi) site influence the equilibrium interactions of the iron sulfur protein and hydroquinone oxidation (Qo) site of the cytochrome bc1 complex. Biochemistry (2005) 1.17
De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly. Am J Hum Genet (2011) 1.17
Missense mutations in the DNA-binding/dimerization domain of NFIX cause Sotos-like features. J Hum Genet (2012) 1.16
Phenotypic spectrum of COL4A1 mutations: porencephaly to schizencephaly. Ann Neurol (2012) 1.11
Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders. Am J Hum Genet (2013) 1.11
Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation. Am J Hum Genet (2011) 1.10
Early infantile epileptic encephalopathy associated with the disrupted gene encoding Slit-Robo Rho GTPase activating protein 2 (SRGAP2). Am J Med Genet A (2011) 1.07
The ND2 subunit is labeled by a photoaffinity analogue of asimicin, a potent complex I inhibitor. FEBS Lett (2010) 1.07
Mitochondrial complex III deficiency caused by a homozygous UQCRC2 mutation presenting with neonatal-onset recurrent metabolic decompensation. Hum Mutat (2013) 1.06
Stimulation of perivascular nitric oxide synthesis by oxygen. Am J Physiol Heart Circ Physiol (2002) 1.04
Characterization of the iron-sulfur cluster N7 (N1c) in the subunit NuoG of the proton-translocating NADH-quinone oxidoreductase from Escherichia coli. J Biol Chem (2004) 1.02
Clinical correlations of mutations affecting six components of the SWI/SNF complex: detailed description of 21 patients and a review of the literature. Am J Med Genet A (2013) 0.99
New insights into the superoxide generation sites in bovine heart NADH-ubiquinone oxidoreductase (Complex I): the significance of protein-associated ubiquinone and the dynamic shifting of generation sites between semiflavin and semiquinone radicals. Biochim Biophys Acta (2010) 0.98
De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum Mutat (2013) 0.98
SMOC1 is essential for ocular and limb development in humans and mice. Am J Hum Genet (2010) 0.97
Royal jelly prevents osteoporosis in rats: beneficial effects in ovariectomy model and in bone tissue culture model. Evid Based Complement Alternat Med (2006) 0.97
Targeted capture and sequencing for detection of mutations causing early onset epileptic encephalopathy. Epilepsia (2013) 0.96
Characterization of the iron-sulfur cluster coordinated by a cysteine cluster motif (CXXCXXXCX27C) in the Nqo3 subunit in the proton-translocating NADH-quinone oxidoreductase (NDH-1) of Thermus thermophilus HB-8. J Biol Chem (2001) 0.96
Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo. Nanomedicine (2011) 0.95
Identification of the residues involved in stabilization of the semiquinone radical in the high-affinity ubiquinone binding site in cytochrome bo(3) from Escherichia coli by site-directed mutagenesis and EPR spectroscopy. Biochemistry (2002) 0.95
CASK aberrations in male patients with Ohtahara syndrome and cerebellar hypoplasia. Epilepsia (2012) 0.94
Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia. J Hum Genet (2013) 0.94
Possible roles of two quinone molecules in direct and indirect proton pumps of bovine heart NADH-quinone oxidoreductase (complex I). Biochim Biophys Acta (2010) 0.94
Structural biology: Piston drives a proton pump. Nature (2010) 0.92
A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process. Microvasc Res (2011) 0.91
Potential role of regucalcin as a specific biochemical marker of chronic liver injury with carbon tetrachloride administration in rats. Mol Cell Biochem (2002) 0.90
Iron-sulfur cluster N5 is coordinated by an HXXXCXXCXXXXXC motif in the NuoG subunit of Escherichia coli NADH:quinone oxidoreductase (complex I). J Biol Chem (2008) 0.90
De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy. Am J Med Genet A (2011) 0.90
Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells. J Cell Biochem (2003) 0.89
PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy. Neurogenetics (2013) 0.89
A family of oculofaciocardiodental syndrome (OFCD) with a novel BCOR mutation and genomic rearrangements involving NHS. J Hum Genet (2012) 0.88
PIGA mutations cause early-onset epileptic encephalopathies and distinctive features. Neurology (2014) 0.88
Overexpression of regucalcin suppresses cell death in cloned rat hepatoma H4-II-E cells induced by tumor necrosis factor-alpha or thapsigargin. J Cell Biochem (2004) 0.88
Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions. Thromb Haemost (2012) 0.87
Performance comparison of bench-top next generation sequencers using microdroplet PCR-based enrichment for targeted sequencing in patients with autism spectrum disorder. PLoS One (2013) 0.86
A unique case of de novo 5q33.3-q34 triplication with uniparental isodisomy of 5q34-qter. Am J Med Genet A (2013) 0.86
Breakpoint determination of X;autosome balanced translocations in four patients with premature ovarian failure. J Hum Genet (2010) 0.86
Aortic aneurysm and craniosynostosis in a family with Cantu syndrome. Am J Med Genet A (2013) 0.86
Oral administration of beta-cryptoxanthin induces anabolic effects on bone components in the femoral tissues of rats in vivo. Biol Pharm Bull (2004) 0.85
A de novo 1.4-Mb deletion at 21q22.11 in a boy with developmental delay. Am J Med Genet A (2014) 0.85
A hemizygous GYG2 mutation and Leigh syndrome: a possible link? Hum Genet (2013) 0.85
PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels. Epilepsia (2014) 0.85
Overexpression of regucalcin suppresses apoptotic cell death in cloned normal rat kidney proximal tubular epithelial NRK52E cells: change in apoptosis-related gene expression. J Cell Biochem (2005) 0.85
Ki-energy (life-energy) stimulates osteoblastic cells and inhibits the formation of osteoclast-like cells in bone cell culture models. Evid Based Complement Alternat Med (2007) 0.84
Whole-exome sequencing identified a homozygous FNBP4 mutation in a family with a condition similar to microphthalmia with limb anomalies. Am J Med Genet A (2013) 0.84
A girl with early-onset epileptic encephalopathy associated with microdeletion involving CDKL5. Brain Dev (2011) 0.84
Novel compound heterozygous PIGT mutations caused multiple congenital anomalies-hypotonia-seizures syndrome 3. Neurogenetics (2014) 0.84
beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J Cell Biochem (2005) 0.83
A de novo deletion of 20q11.2-q12 in a boy presenting with abnormal hands and feet, retinal dysplasia, and intractable feeding difficulty. Am J Med Genet A (2011) 0.83
Characterization of cluster N5 as a fast-relaxing [4Fe-4S] cluster in the Nqo3 subunit of the proton-translocating NADH-ubiquinone oxidoreductase from Paracoccus denitrificans. J Biol Chem (2003) 0.83
Oral administration of beta-cryptoxanthin prevents bone loss in ovariectomized rats. Int J Mol Med (2006) 0.83
Role of regucalcin in liver nuclear function: binding of regucalcin to nuclear protein or DNA and modulation of tumor-related gene expression. Int J Mol Med (2004) 0.82
Electron transfer in subunit NuoI (TYKY) of Escherichia coli NADH:quinone oxidoreductase (NDH-1). J Biol Chem (2012) 0.82
Pathogenic mutations in two families with congenital cataract identified with whole-exome sequencing. Mol Vis (2013) 0.82
Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells. J Cell Biochem (2007) 0.82
Role of endogenous regucalcin in nuclear regulation of regenerating rat liver: suppression of the enhanced ribonucleic acid synthesis activity. J Cell Biochem (2002) 0.82
Enhancement of albumin expression in bone tissues with healing rat fractures. J Cell Biochem (2003) 0.82
Albumin regulates Runx2 and alpha1 (I) collagen mRNA expression in osteoblastic cells: comparison with insulin-like growth factor-I. Int J Mol Med (2005) 0.82
Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals. Thromb Res (2013) 0.82
Overexpression of regucalcin enhances its nuclear localization and suppresses L-type Ca2+ channel and calcium-sensing receptor mRNA expressions in cloned normal rat kidney proximal tubular epithelial NRK52E cells. J Cell Biochem (2006) 0.81
Role of endogenous regucalcin in transgenic rats: suppression of kidney cortex cytosolic protein phosphatase activity and enhancement of heart muscle microsomal Ca2+-ATPase activity. J Cell Biochem (2002) 0.81
Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol (2004) 0.81
Fibroblast growth factor receptor 3 (FGFR3) associated with the CD20 antigen regulates the rituximab-induced proliferation inhibition in B-cell lymphoma cells. J Biol Chem (2012) 0.81
Suppressive role of endogenous regucalcin in the enhancement of deoxyribonucleic acid synthesis activity in the nucleus of regenerating rat liver. J Cell Biochem (2002) 0.81
Alteration in serum and bone component findings induced in streptozotocin-diabetic rats is restored by zinc acexamate. Int J Mol Med (2003) 0.81
Severe manifestations of hand-foot-genital syndrome associated with a novel HOXA13 mutation. Am J Med Genet A (2014) 0.81
Nuclear localization of regucalcin is enhanced in culture with protein kinase C activation in cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med (2008) 0.80
Nuclear localization of a novel protein, RGPR-p117, in cloned normal rat kidney proximal tubular epithelial cells. Int J Mol Med (2005) 0.80
Hormonal regulation on regucalcin mRNA expression in cloned normal rat kidney proximal tubular epithelial NRK52E cells. J Cell Biochem (2005) 0.80
Rapid detection of gene mutations responsible for non-syndromic aortic aneurysm and dissection using two different methods: resequencing microarray technology and next-generation sequencing. Hum Genet (2011) 0.80
A novel regucalcin gene promoter region-related protein: comparison of nucleotide and amino acid sequences in vertebrate species. Int J Mol Med (2005) 0.80
Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by lipopolysaccharide, PD 98059, dibucaine, or Bay K 8644. J Cell Biochem (2004) 0.80
De novo deletion of 1q24.3-q31.2 in a patient with severe growth retardation. Am J Med Genet A (2010) 0.80
Phytocomponent p-hydroxycinnamic acid inhibits osteoclast-like cell formation in mouse bone marrow cultures. Int J Mol Med (2007) 0.80